We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 19
Most popular |Most recent


Federal Circuit Splits on Approach to Analyzing Graham Factors

USA - November 6 2017 In Merck Sharp & Dohme Corp. v. Hospira, Inc.,1 the Federal Circuit affirmed the lower court’s ruling that the asserted claims of Merck’s U.S...

Wade Haaland, David N. Farsiou.


The Federal Circuit Provides a Tutorial on Patent Venue

USA - September 27 2017 The Federal Circuit in In re Cray, Inc., Appeal No. 2017-129 (Fed. Cir. Sept. 21, 2017), has provided extensive guidance to district courts on the...


Federal Circuit Suggests Solution to Patent Owner’s Dilemma When Applicant for Biosimilar Product Refuses Discovery

USA - August 14 2017 In Amgen, Inc. v. Hospira, Inc., Appeal No. 2016-2179 (Fed. Cir. Aug. 10, 2017), the Federal Circuit suggested what an owner of a reference product...


The Federal Circuit Reverses a Hindsight Reconstruction of An Important Pharmaceutical Invention

USA - July 20 2017 In Millennium Pharmaceuticals v. Sandoz,1 the Federal Circuit reversed the district court’s holding of obviousness of certain claims of...

Laura R. Gordon, Stephanie A. Lodise.


The Federal Circuit Invalidates a Patent for Failure to Describe the Accused Product

USA - May 31 2017 In Rivera v. International Trade Commission, Appeal No. 2016-1841 (Fed. Cir. May 23, 2017), the Federal Circuit affirmed the ITC’s decision...